Bio-Rad Laboratories Inc.
BIO | NYSE
$371.63
-$0.55 (-0.15%)
Nov 2, 2026, 12:53 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -13.3M | -527.1M | 720M | -341.9M | -120.1M | 64M | -715.8M | 653.2M | -2.17B | 383.9M | 349.7M | 106.3M | -1.16B | 69M | 833.5M | -162.8M | -925.2M | -3.37B | -1.57B | 3.93B | 914.1M | 977.4M |
Depreciation & Amortization | n/a | 40.9M | 42.5M | 44.2M | -38.1M | 38.1M | 49.3M | 38.9M | 36.4M | 37.1M | 37.2M | 37.3M | 35.8M | 35.6M | 40M | 34.3M | 34.1M | 33.4M | 33.7M | 33.7M | 33.7M | 32.7M |
Stock-Based Compensation | n/a | 15M | 15.9M | 14.9M | -15.3M | 15.3M | 16.4M | 15.6M | 15M | 15.3M | 16.2M | 15.9M | 12.6M | 16.6M | 18.1M | 15.7M | 13.6M | 13.5M | 15M | 13.1M | 11.4M | 11.7M |
Other Working Capital | 13.1M | -179M | 199.9M | -86.9M | 5.5M | -5.5M | 58.35M | 210.7M | -670.5M | 69.8M | -24M | 15.2M | -320.3M | -17M | 224.3M | -98.8M | -339.8M | -1.05B | -531.6M | 1.07B | 196.3M | 308.4M |
Other Non-Cash Items | 109.4M | 747.8M | -867.6M | 506.1M | 333.6M | -31.1M | 717.3M | -764.79M | 2.89B | -420.51M | -313.85M | -59.29M | 1.59B | 17.22M | -949.88M | 296.23M | 1.34B | 4.55B | 2.16B | -4.87B | -1.03B | -1.18B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.6M | -168.5M | 254.1M | -102.4M | -43.6M | 43.6M | 56.95M | 220.7M | -679.5M | 54M | -8.2M | -2.5M | -381.8M | -40.3M | 148.7M | -172.4M | -409.8M | -1.17B | -475.8M | 1.12B | 226.7M | 271M |
Operating Cash Flow | 98.7M | 108.1M | 164.9M | 120.9M | 116.5M | 129.9M | 124.15M | 163.61M | 97.65M | 69.79M | 81.05M | 97.71M | 98.07M | 98.12M | 90.42M | 11.03M | 53.27M | 50.49M | 157.92M | 230.36M | 154.62M | 113.61M |
Capital Expenditures | -32M | -30M | -45.8M | -31.7M | -45.7M | -34.4M | -42.9M | -63.64M | -42.28M | -40.18M | -42.25M | -44.07M | -34.64M | -35.73M | -46.93M | -27.58M | -17.33M | -33.08M | -43.24M | -34.63M | -23.39M | -19.55M |
Cash Acquisitions | -100K | 100K | n/a | -1.8M | -216.6M | n/a | n/a | n/a | n/a | n/a | 2.5M | n/a | n/a | n/a | n/a | -100.75M | n/a | n/a | -125.52M | n/a | n/a | n/a |
Purchase of Investments | -184.2M | -226.1M | -138.8M | -223.9M | -153.2M | -153.4M | -222.94M | -399.12M | -248.08M | -406.46M | -151.5M | -196.02M | -137.93M | -203.59M | -253.09M | -328.72M | -517.49M | -960.94M | -845.01M | -204.78M | -180.35M | -74.93M |
Sales Maturities Of Investments | 148.5M | 162.8M | -643.2M | 214.4M | 300.1M | 190.7M | 235.35M | 407.07M | 259.37M | 403.52M | 263.34M | 230.52M | 200.52M | 168.84M | 230.66M | 368.61M | 388.88M | 77.88M | 459.28M | 158.02M | 103.46M | 46.13M |
Other Investing Acitivies | 1.1M | n/a | 793.6M | n/a | n/a | n/a | -39K | -23.35M | 66K | 26K | 107K | 65K | 39K | n/a | -1.33M | 6K | 1.47M | n/a | n/a | 39K | 1K | 12K |
Investing Cash Flow | -66.7M | -93.2M | -34.2M | -43M | -115.4M | 2.9M | -30.54M | -55.64M | -30.93M | -43.09M | 72.2M | -9.5M | 27.98M | -70.47M | -69.32M | -88.42M | -144.48M | -916.14M | -554.48M | -81.35M | -100.28M | -48.33M |
Debt Repayment | -300K | -100K | -200K | -300K | -200K | -100K | -41K | -123K | -118K | -118K | -118K | -118K | -116K | -115K | -143K | -113K | -150K | 1.19B | -1.38M | -122K | -122K | -1.4M |
Common Stock Repurchased | -31.5M | -47.8M | n/a | -53.4M | -140.2M | -101.9M | -14K | -97.84M | -101M | -4.75M | -200M | -21.32M | -207.41M | n/a | -90.68M | n/a | -125M | n/a | n/a | n/a | -507K | -50M |
Dividend Paid | -15.7M | -33.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -56.3M | 33.8M | -400K | -2.2M | -100K | 4.3M | -26.19M | 1.97M | 4.53M | 4.89M | -502K | -5.16M | 4.79M | n/a | 4.2M | -13.43M | 3.82M | 4.18M | -162K | -21.81M | 3.49M | 4.05M |
Financial Cash Flow | -27.9M | -44M | 3.3M | -52.5M | -136.3M | -97.7M | -26.25M | -95.99M | -96.59M | 21K | -200.62M | -26.6M | -202.74M | 4.31M | -86.62M | -8.77M | -121.33M | 1.19B | 4.64M | -15.58M | 2.87M | -47.35M |
Net Cash Flow | 9.5M | -23.2M | 132M | 26.5M | -151.4M | 33.3M | 77.61M | 4.47M | -26.04M | 29.38M | -53.95M | 67.83M | -74.02M | 29.96M | -83.7M | -78.66M | -205.75M | 331.52M | -393.39M | 127.36M | 59.46M | 10.59M |
Free Cash Flow | 66.7M | 78.1M | 119.1M | 89.2M | 70.8M | 95.5M | 81.25M | 99.97M | 55.37M | 29.62M | 38.8M | 53.64M | 63.43M | 62.39M | 43.49M | -16.55M | 35.94M | 17.42M | 114.68M | 195.74M | 131.24M | 94.06M |
Adj. Free Cash Flow | 66.7M | 63.1M | 103.2M | 74.3M | 86.1M | 80.2M | 64.85M | 84.37M | 40.37M | 14.32M | 22.6M | 37.74M | 50.83M | 45.79M | 25.39M | -32.25M | 22.34M | 3.92M | 99.68M | 182.64M | 119.84M | 82.36M |
Maintenance CapEx | n/a | -30M | -38.93M | -30.83M | -42.2M | -34.4M | -42.9M | -59.06M | -42.28M | -40.18M | -42.25M | -44.07M | -34.64M | -35.73M | -46.93M | -27.58M | -17.33M | -33.08M | -43.24M | -9.92M | n/a | n/a |
Growth CapEx | -32M | n/a | -6.87M | -873.23K | -3.5M | n/a | n/a | -4.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.7M | -23.39M | -19.55M |
Owner Earnings | 98.7M | 78.1M | 125.97M | 90.07M | 74.3M | 95.5M | 81.25M | 104.55M | 55.37M | 29.62M | 38.8M | 53.64M | 63.43M | 62.39M | 43.49M | -16.55M | 35.94M | 17.42M | 114.68M | 220.44M | 154.62M | 113.61M |
Add to Watchlist
Select watchlists to add or remove BIO